Src Homology 2 and Phosphotyrosine-binding domains (SH2 and PTB)

Src Homology 2 (SH2) and Phosphotyrosine-binding (PTB) domains are critical protein modules that mediate intracellular signal transduction by recognizing and binding to phosphorylated tyrosine (pTyr) residues on partner proteins [Pawson, 2004]. SH2 domains are the most common pTyr-recognition modules, typically binding pTyr within a specific C-terminal sequence context, whereas PTB domains often recognize pTyr within an NPxY motif [Forman-Kay & Pawson, 1999]. These domains are found in a wide variety of signaling proteins, including adaptor proteins like Grb2 and Shc, as well as transcription factors like STAT proteins, allowing for the assembly of multi-protein complexes in response to extracellular stimuli [Schlessinger & Lemmon, 2003]. Because many oncogenic and inflammatory pathways rely on these interactions, SH2 and PTB domains are significant therapeutic targets, particularly in cancer and autoimmune diseases [Machida & Mayer, 2005]. Small molecule inhibitors and peptidomimetics have been developed to block these domains, thereby disrupting aberrant signaling cascades, such as the STAT3 pathway in various malignancies [Filippakopoulos et al., 2009]. However, the high degree of structural conservation among different SH2 or PTB domains poses a significant challenge for achieving the high selectivity required for clinical safety [Kuriyan & Cowburn, 1997].

Other names

SH2 domainsPTB domainsPhosphotyrosine-binding modulesSrc Homology 2 domainsPhosphotyrosine-binding domains

Competitive inhibition of phosphotyrosine binding to disrupt protein-protein interactions and downstream signaling cascades [Machida & Mayer, 2005].